Novoheart, a Vancouver-based stem cell biotech company, is pairing with biopharmaceutical giant AstraZeneca to develop the world’s first human-specific in vitro functional model of heart failure with preserved ejection fraction.

Brushing teeth three or more times a day could dramatically lower a person’s risk for CVDs like heart failure and atrial fibrillation, according to preliminary research out of Ewha Womans University in Seoul, South Korea.

Abbott’s transcatheter tricuspid valve repair system is a safe and effective approach to treating tricuspid regurgitation in heart patients with few other options, according to data published in The Lancet.

Surgical candidates with active cannabis use disorders were nearly twice as likely as their non-user peers to suffer a heart attack after surgery, according to research published in Anesthesiology on Nov. 25.

A study published in the European Journal of Cardiovascular Nursing Nov. 28 found that nearly half of heart patients undergoing PCI admit to not understanding or remembering the bulk of the informed consent process, leaving them without a clear picture of the procedure and its potential benefits.

Researchers have established a strong connection between depression and heart disease or stroke, with more severe cases of the mood disorder tied to increasingly greater odds of adverse CV events.

A cardiologist in Madrid, Spain, thinks physicians could leverage data from later-generation Apple Watches to diagnose heart attacks, HealthDay News reported Nov. 25.

More than 10% of cancer patients in the U.S. die not from their cancer but from cardiovascular complications, according to a study published in the European Heart Journal Nov. 25.